[1] The Merck index, 12th Ed., Merck and Co. Inc., White House Stations, NJ, pp. 1205 (1997).
[2] Current Index of Medical Specialities (CIMS), CMP Medica India Pvt Ltd., Bangalore, India, July-October, pp. 76 (2005).
[3] Ding, G., Tang, A., Wang, J., Cong, R. and Bao, J., Direct Enantioseparation of Pantoprazole Sodium by High Performance Liquid Chromatography on Teicoplanin-Bonded Chiral Stationary Phase, Sepu., 24, 46 (2006), 2006 ACS on Scifinder; CAN 144:199119; AN 2006:141860.
[4] Ding, G., Cong, R., and Wang, J., Direct Enantio Separation of Pantoprazole Sodium by High Performance Liquid Chromatography, Sepu., 22, 241 (2004), 2006 ACS on Scifinder; CAN 141:59853; AN 2004:563455.
[5] Xue-Hui, H. and Fu-Sheng, P., Determination of Pantoprazole Sodium in Capsules by HPLC, Zhongguo Yiyao Gongye Zazhi, 31, 502 (2000), ACS on Scifinder; CAN 134:91243; AN 2001:52063.
[6] Agbaba, D., Novovic, D., Karljikovic-Rajic, K. and Marinkovic, V., Densitometric Determination of Omeprazole, Pantoprazole, and their Impurities in Pharmaceuticals, J. Planar Chromatogr. Mod. TLC., 17, 169 (2004).
[7] Karljikovic-Rajic, K., Novovic, D., Marinkovic, V. and Agbaba, D., First-order UV-Derivative Spectrophotometry in the Analysis of Omeprazole and Pantoprazole Sodium Salt and Corresponding Impurities, J. Pharm. Biomed., Anal., 32, 1019 (2003).
[8] Wahbi Abdel-Aziz, M., Abdel-Razak, O., Gazy, A. A., Mahgoub, H., and Moneeb, M. S., Spectro-photometric Determination of Omeprazole, Lansoprazole and Pantoprazole in Pharmaceutical Formulations, J. Pharm. Biomed. Anal., 30, 1133 (2002).
[9] Salama, F., El-Abasawy, N., Razeq, S. A. A., Ismail, M. F. and Fouad, M. M., Spectrophotometric Determination of Omeprazole and Pantoprazole Sodium via Chelates with Iron, Chromium, and Cobalt, Bull. Fac. Pharm (Cairo University), 41, 185 (2003).
[10] Moustafa, A. A. M., Spectrophotometric Methods for the Determination of Lansoprazole and Panto-prazole Sodium Sesquihydrate, J. Pharm. Biomed. Anal., 22, 45 (2000).
[11] Berka, A., Vulterin, J. and Zyka, J., Newer Redox Titrants (Pergamon Press, London) 38(1965).
[12] International Conference on Hormonisation of Technical Requirements for Registration of Pharma-ceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.